Save money on Medications - TheDrugCompany.com
Prostate Cancer >> The PC Article Base >> Treating Bone Loss in Prostate Cancer Survivors

Treating Bone Loss in Prostate Cancer Survivors

Save & Share - Leave a Comment

Prostate cancer survivors and their medical physicians are showing signs of concern for the rising account of osteoporosis among cancer survivors. One of the thoughts behind this is from the variety of cancer drugs that the medical community is feeding to the prostate cancer men to eradicate the cancer. Osteoporosis is a growing concern, as this is becoming a direct side effect.

Prostate cancer drugs are many, but a specific one, aromatase inhibitor found to decrease the bone mineral density and increase the fracture risks in the many of the prostate cancer patients. This was an astounding find for the medical community to come across. Men who have gone through having chemotherapy, surgery and even tried hormonal therapy believing it will work and help them to be prostate cancer free.

Hormonal therapy works differently than many other therapies. Hormonal therapy works against the hormone receptor in prostate cancer. The hormonal therapeutic medications are treatments to fight prostate cancer in a couple of ways.

Treatments, surgeries, and all medications through the various ordeals can leave you with a few side effects, though most men fair well. A few of the more pronounced side effects are the following.

Cancer treatment lasting pain

Bone pain because the cancer can spread

Urinary dysfunction caused by radiation therapy

Bowel dysfunction usually following external beam radiotherapy

Erectile dysfunction

Clinical, biological, and pathological features of prostate cancer in younger men like you vary from older men. If you receive a diagnosis of prostate cancer before reaching age forty this is an indication of a more serious condition that is more than likely a part of the gene pool with the male members of your family. In many cases by the time prostate cancer is even noticeable, the cancer has spread and become more advanced. However, what you do have in your favor is the fact that younger men generally respond better.

Men receiving a diagnosis of prostate cancer may want to consider having counseling first before beginning any further treatments. Another possibility for the man to consider is to possibly try hormonal therapies before going full swing into the heavy cancer fighting drugs.

There are a few drugs to help counter the turmoil the body is going through. Now it is time to learn the rebuilding of the bones and the man’s body to continue to gain strength and live out a normal, happy, and very healthy life. Some of these new medications are the following:

Osteoporosis drugs such as bisphosphonates

Osteoporosis drugs such as alendronate sodium

Osteoporosis drugs such as Fosamax

Osteoporosis drugs such as ibandronate sodium

Osteoporosis drugs such as Boniva

Studies found that the prostate cancer medication and treatments currently in use to treat prostate cancer are not alone. There are other drugs, and the lack of vitamin D is also contributory factors in the pending ill health after men survive prostate cancer. Another unknown is the frequency of vitamins and the strength of vitamins. There is currently a study to find out exactly what role vitamins play in the regaining of strength in the prostate cancer patients. If this are found to be accurate this would then apply to other cancer patients.

Studies of aromatase inhibitors seem to decrease the body’s production of men receiving treatment for prostate cancer. Strangely enough it found that certain internal entities feeds cancer and at the same time aromatase inhibitors protect against osteoporosis. What the medical community found is that the aromatase inhibitors letrozole and exemestane in this study go along well with the prostate cancer treatments.

Studies also found that the majority of men under treatment for prostate cancer experienced different levels of bone loss due to the lack of vitamin D and from the excessive calcium excretion in the urine found in a number of prostate cancer patients. This study was a real opener for the medical community as a whole.

Related Articles

Write a comment